Kathiresan Sekar (CIK 1864112) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-07-28). Recent activity: Sell VERV (348,431 shares), Sell VERV (110,997 shares), Sell VERV (240,997 shares), Buy VERV (33,000 shares), Sell VERV (9,822 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) | Chief Executive Officer | Sell | 348,431 | $0 |
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) | Chief Executive Officer | Sell | 110,997 | $0 |
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) | Chief Executive Officer | Sell | 240,997 | $0 |
| 2025-04-03 | Verve Therapeutics, Inc. (VERV) | Chief Executive Officer | Buy | 33,000 | $0 |
| 2025-04-03 | Verve Therapeutics, Inc. (VERV) | Chief Executive Officer | Sell | 9,822 | $40,761 |
Source: SEC Form 4 filings · as of 2025-07-28